Voss Value Master Fund, LP 13D and 13G filings for Rein Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-14 8:26 pm Purchase |
2025-05-08 | 13G | Rein Therapeutics Inc. RNTX |
Voss Value Master Fund, LP | 1,277,856 5.600% |
1,277,856 (New Position) |
Filing |